|
Kearns-Sayre Syndrome Reviewed 12-27-2001 Get Web page suited for printing Email this to a friend or colleague Studies with patients Table of Contents (click to jump to sections) What is Kearns-Sayre Syndrome?Is there any treatment? What is the prognosis? What research is being done? Organizations What is Kearns-Sayre Syndrome? Kearns-Sayre syndrome (KSS) is a rare neuromuscular disorder with onset usually before the age of 20. It is characterized by progressive external ophthalmoplegia (paralysis of the eye muscles) and mild skeletal muscle weakness. It may also be associated with other manifestations such as retinal pigmentation (abnormal accumulation of pigmented material on the membrane lining the eyes), cardiac conduction defects, short stature, hearing loss, increased cerebrospinal fluid protein, inability to coordinate voluntary movements (ataxia), impaired cognitive dysfunction, diabetes, and other endocrine disorders. Is there any treatment? What is the prognosis? What research is being done? Muscular Dystrophy Association
National Organization for Rare Disorders (NORD)
United Mitochondrial Disease Foundation
NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history. All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated. Provided by: | |||